Page last updated: 2024-08-26

bosentan anhydrous and Behcet Syndrome

bosentan anhydrous has been researched along with Behcet Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Daele, PLAV; Dik, WAV; Hagen, PMV; Houwen, TBV; Kappen, JH; Kuijpers, RWAM; Laar, JAMV1

Trials

1 trial(s) available for bosentan anhydrous and Behcet Syndrome

ArticleYear
A pilot study into bosentan (Tracleer®) as an immunomodulating agent in patients with Behçet's disease.
    Asian Pacific journal of allergy and immunology, 2022, Volume: 40, Issue:4

    Topics: Behcet Syndrome; Bosentan; Cytokines; Endothelial Cells; Humans; Pilot Projects; Prospective Studies

2022